Fennec Pharmaceuticals's total assets for Q4 2024 were $44.95M, a decrease of -23.72% from the previous quarter. TSE:FRX total liabilities were $50.82M for the fiscal quarter, a -20.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.